{"name":"Orient Pharma Co., Ltd.","slug":"orient-pharma-co-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"1PC111","genericName":"1PC111","slug":"1pc111","indication":"Advanced solid tumors with PI3K/AKT pathway alterations","status":"phase_3"},{"name":"1PC002","genericName":"1PC002","slug":"1pc002","indication":"Metastatic breast cancer","status":"phase_3"}]},{"name":"Neuroscience","slug":"neuroscience","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"ORADUR®-Methylphenidate","genericName":"ORADUR®-Methylphenidate","slug":"oradur-methylphenidate","indication":"Attention deficit hyperactivity disorder (ADHD) in children and adults","status":"phase_3"}]},{"name":"Pain","slug":"pain","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"cardiovascular","drugs":[{"name":"Placebo First, then ORADUR®","genericName":"Placebo First, then ORADUR®","slug":"placebo-first-then-oradur","indication":"Moderate to severe pain","status":"phase_3"}]}],"pipeline":[{"name":"1PC111","genericName":"1PC111","slug":"1pc111","phase":"phase_3","mechanism":"This drug is a small molecule that targets the PI3K/AKT pathway.","indications":["Advanced solid tumors with PI3K/AKT pathway alterations"],"catalyst":""},{"name":"1PC002","genericName":"1PC002","slug":"1pc002","phase":"phase_3","mechanism":"This drug is a small molecule that targets the PI3K/AKT/mTOR pathway.","indications":["Metastatic breast cancer","Metastatic colorectal cancer"],"catalyst":""},{"name":"ORADUR®-Methylphenidate","genericName":"ORADUR®-Methylphenidate","slug":"oradur-methylphenidate","phase":"phase_3","mechanism":"ORADUR-Methylphenidate is an extended-release formulation of methylphenidate that inhibits the reuptake of dopamine and norepinephrine in the central nervous system.","indications":["Attention deficit hyperactivity disorder (ADHD) in children and adults"],"catalyst":""},{"name":"Placebo First, then ORADUR®","genericName":"Placebo First, then ORADUR®","slug":"placebo-first-then-oradur","phase":"phase_3","mechanism":"ORADUR is a sustained-release formulation of buprenorphine.","indications":["Moderate to severe pain"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxOLVlJc3JXdTZCR3pKMHhLclJMV0NhYksyQzJjZm5vOENGSUFQRzFIdHBvdzFvYXB3a3pSWGQ3RWtHZEpHMEJJcHZJXy1HdnNsejQ3TzV0bmZoenBMeFBCbjZwWERaekl3ZVJ4amcxNDlkZzJlM2V4VXgwLVdKSnhXYzFMSUVtcUkzNHlTei1IM254eF9TeHBQZzJR?oc=5","date":"2026-04-06","type":"trial","source":"openPR.com","summary":"Knee Osteoarthritis Clinical Trial Pipeline Appears Robust - openPR.com","headline":"Knee Osteoarthritis Clinical Trial Pipeline Appears Robust","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi9wFBVV95cUxPWE5PeDl6VGpTS2dfMDZUcVk1STN4LUhpdkJwS19NX0RCamlac2NzbGw5N3hkdTg1Q2xUd1VHLWZTQjdpLXlIdXhycFIycnMwSWxxRXlVcDNMblQtTEVnRjlSXzdvNHVzUThNN3VBMExMRnB0QmlhUmRWSXh0Y1RiZnhka3ZNTmtHekcydVJoSXNGS3EzM2RBNExyRVhuMTh0SzdFc1JGdzBKRVNTNVRnamlTQkYxQXlQOTczUzl3aEZ2WDZ1WUJfZllBb0diSWZmMDJBUFpsdzNIak9UcWRNREYzdll2SjJWT2ZORFBxQkdSWk1tRGww?oc=5","date":"2026-03-03","type":"deal","source":"Citeline News & Insights","summary":"Deal Watch: Esperion Augments Cardiovascular Franchise Via Corstasis Buyout - Citeline News & Insights","headline":"Deal Watch: Esperion Augments Cardiovascular Franchise Via Corstasis Buyout - Citeline News & Insights","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAJBVV95cUxQZi1XRDN6bG5yd0Qyb29yODYyVFBQX3FqWDJHZmFOMjc5TEhGd1lZazg5QXdPSWFuczVfa0FtN2RYSUZIaEhwU21yX0M5WjlqQUlWNG96aVFGRGN4TG1Hd2V5bVVQbGRmcENEVDJjSTFRMjlkNVN5bUJ4ODE5ZTVKR2NNTkZ6WnBnWjI2c2NzQzgwUXBucHRkOTdWTWZ6RWEtb2FjQ2FsYkFzUzJLMXpsOUZPbzg1ZG9JNXltc00wRlFvdnJOMjBfSXdEeFB2cmVIajcyS3lZSjNEVzBEUnYwWkIzVmlPbHE3aFBsQXZoMDVyeGZuSmpEb1dWQ2Rfc0lRYVBJOFowWnhPTmp4MGxycURFbTdmMExFVm1KRFllQjh5WlRkOExwWWtyeWdsbjZy?oc=5","date":"2026-02-13","type":"earnings","source":"Upstox","summary":"Q3 Results: Torrent Pharma, GMR Airports, Info Edge, Fortis, Ola Electric, KFin Tech, FirstCry, others to release earnings on Feb 13; check list - Upstox","headline":"Q3 Results: Torrent Pharma, GMR Airports, Info Edge, Fortis, Ola Electric, KFin Tech, FirstCry, others to release earnin","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi-AFBVV95cUxQVi1JS0FybUNKV1lBa3NaVG5TMXQyVHE0OWFuTmgyaDU3c2xOakNabGtLajRObmY5ZFZrLU84dTJwcGREQ2N6NktnUXk5Z25Zd0tObUZqd1FkclZBM0l2ZTl3LVRPaTdRS1N4SXZ1cVpmbkVjdml5QTM1b21idGM4YjZiUjRodzV3Tm0tdzBIdllhM09kWU1iTFlaVHptUmJIVjl4WGFBeVNxb0V1QXlrUXNrcDFoSGpmWHJrTlp2aE9ta01rR0phelhUcXFrNWxKOTJ0dEFaSmxLZE8zUzVBRE9WYjVUcWhmemJybWh1dXlRR2w0Q1U5LQ?oc=5","date":"2025-08-25","type":"deal","source":"PR Newswire","summary":"Neopharma Technologies and Orient Gene Partner to Digitize Healgen® Drug Test Portfolio Globally with NEOVAULT® - PR Newswire","headline":"Neopharma Technologies and Orient Gene Partner to Digitize Healgen® Drug Test Portfolio Globally with NEOVAULT®","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxQTW1HMDdoVjQxNmRCUVZscnd2c2poRmlmb294bnFvUk96ajh1c0hzb3VOMXZ2ZFFyNFBlYklLZTVsVElOcnIzbzl2WkRmNlZyRFkxSU44Q2tTWXhycVlmWWdHWTNmUmlQeTNOZTRxWHFQM3hwTk9XQ21RNlBUU19GTl9xUmhMOUpndTRsNDQ5Z1ZEV0JWQmt4eHl0bHBoS0k1MEtmTXVVUlk3RXE1QUNlbjl6QnRueHVva0Q1aHdHNnh1RXM?oc=5","date":"2025-08-20","type":"pipeline","source":"Fierce Pharma","summary":"Alembic, Sun and Glenmark issue US drug recalls due to the presence of carcinogens or foreign matter - Fierce Pharma","headline":"Alembic, Sun and Glenmark issue US drug recalls due to the presence of carcinogens or foreign matter","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxNVmotYWozYjRQREtrLWJBVkxuU3hLX0VtRDMyRjJtWkpoQmFRaGxPUE91QVducV9LODBTMHpMdU5nWGJieDlrYVdqMmpoc1pxTGhISi1PeDV6WWZ2b2t2UGdvd2RuNjAwMUhOZEJqMVN6ZjlSaXg2UWdiU29jVFNvVHZQcngydmt3d1piYjFVdHhBeDl6bUZabFNKSGVPZkE0Z3fSAbYBQVVfeXFMT1hZNldKaWJoS2VoLVVjNU95ckxPX2dDOC1PMERhR1pCeXJ5UzJnckhwcFota3hybk1kdW9ZRmNWNlJEOERlbGtjQzZVclFBVmMyc2V6dzNFMC0ta2NuV0xtaG9POFFJZmVpczBybzdma3dsWXB0TUEwbDJORzhqVzdOY1J3RDZIZnNRQjdCcmExZWx3WnFCNVBJMUh1OVhFXzdfVVlmOEdwSlA0cnlRN19ld0laY2c?oc=5","date":"2025-07-21","type":"pipeline","source":"SILive.com","summary":"More than 57K bottles of this medication have been recalled - SILive.com","headline":"More than 57K bottles of this medication have been recalled","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxNNkNnWDRSN2RCdUtFTWUxemF1Tm1keV81dm9jdUJkQTFfN3VVMGFpZW92Rno4NDBrUjV5aVQ1cnRUNEZBQzJHdUtrbTctREY4MGRhbjNjWnJRazdrcWg5UHo0S0taLVBHOG1vTGVKNjRBQmxKNG5icWl4d0U4a0llQ2VPLWRWZk5faDVVUjFHUkhQU3VnYnJnU2Y3WThNRWxxZFlkVGRDRFNERW11LWotemlJUQ?oc=5","date":"2025-07-18","type":"regulatory","source":"NTD News","summary":"FDA Announces Recall of Thousands of Bottles of Statin Drug Used for Cholesterol - NTD News","headline":"FDA Announces Recall of Thousands of Bottles of Statin Drug Used for Cholesterol","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxOcTdhVm1DbDQ0N0RDUVJpLW9zUmRBZlNOTnVsOGFUMnpPMVlpVDB5ZnBRaFZlVnVwSDZTS211UmZfalBQSDhuanpCN2I4QWZ4ejdjMGFfTzNIMFZaV3BlQm9ZT0tqdWgwVEdqZ0l0Z014UUg5a1d5b2psbno3WXVqeGQtNkdxX1I1dV9aSTB4OFdBOGU3X2piaEZjXzk?oc=5","date":"2025-07-17","type":"pipeline","source":"The Healthy","summary":"More than 57,000 Bottles of a Cholesterol Medication Have Been Recalled in One State - The Healthy","headline":"More than 57,000 Bottles of a Cholesterol Medication Have Been Recalled in One State","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxONTBtTU1kNHZPRUlHWUZ1X3pMZldjQlRLVkVvSVpLWjk5eEYxcDZwNmRUSWhwcHVhY0EwOW9Ya2pxYk00dWJLYW5CaktLdWFKUkdOQjNNSEJTX2ZLVEVHVmEzbWRTVVp0bkREaURjUDU2QmVrRkZQa3daTmxURWpndlZoYWVtb2dwcThIOXFXdE9BMVdZZTZDRmhMRzdzYXN6VUpEb0VKR3dSZDVhRTVneTlxU2UtZw?oc=5","date":"2023-06-14","type":"pipeline","source":"McKinsey & Company","summary":"Rewired pharma companies will win in the digital age - McKinsey & Company","headline":"Rewired pharma companies will win in the digital age - McKinsey & Company","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxQY1RRd1U2aFF4ajgyTlhfN3M0bW9rY2tSb2ZMSEthVzFsNHBaLTVQTUxvNjVKTWtDdS1ZVHMyeHZBZHdaakJobHBoY2NxaVAyNk9YM210X3RkNzRuczlMNDdjU1kwb09iWlB2UXZjMURwVE85aXRCd25hTnNLelJjejYycVRYWmhnYzgteE5IcHA5Tk9hWjlaSk0xTFowQk1JS1JLN0lmZ0k3Q1J2VWNJQg?oc=5","date":"2023-03-29","type":"deal","source":"Contract Pharma","summary":"OncoVent, Orient EuroPharma Enter License Agreement for Oregovomab - Contract Pharma","headline":"OncoVent, Orient EuroPharma Enter License Agreement for Oregovomab","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxNNlU4WnNBT0NyZktEb3NWY1hrQ2pHMGdJVjRjUmtUZlNZcW8wRGpfVjZYUUtGVzRRc2I3V25xSjhnQ2tFWGZhOENNZlNGM1JxZTUyb25qcm5fSnlRZ01zTEJhSmFveGxwSkd4NDAtbnNhVGo0QlBMZExqcW43OS03UA?oc=5","date":"2022-12-13","type":"pipeline","source":"Axios","summary":"Monkey export crackdown threatens U.S. pharmaceutical research - Axios","headline":"Monkey export crackdown threatens U.S. pharmaceutical research","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiV0FVX3lxTFBvYkRJYzhwT25fQW9GU1FzUU1fSHFfTFZuWm9sSXVCSjZRd0RSRk51VWMzMU5BRUhRdjVKamlwdldnM3ZaSzJxcFg4UzR1VldvR3JkV1ZHSQ?oc=5","date":"2017-09-08","type":"pipeline","source":"Yahoo Finance Singapore","summary":"Orient EuroPharma Co., Ltd. (4120.TWO) stock price, news, quote and history - Yahoo Finance Singapore","headline":"Orient EuroPharma Co., Ltd. (4120.TWO) stock price, news, quote and history","sentiment":"neutral"}],"patents":[],"drugCount":4,"phaseCounts":{"phase_3":4},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}